CFM
NBP

Catalyst Funds Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Catalyst Funds Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-90
Closed -$150 – 1444
2024
Q2 		$150 Sell
90
-146,200
-100% -$261K ﹤0.01% 1136
2024
Q1 		$272K Buy
+146,290
New +$270K 0.08% 206

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Catalyst Funds Management's NBP Position: Q3 2024 in Review

Catalyst Funds Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 90 shares — an estimated $150 sold.

Catalyst Funds Management first reported a position in NBP in Q1 2024 and held it in 2 quarters. The position peaked at $272K in Q1 2024. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

  • Catalyst Funds Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 90 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $150.
  • Catalyst Funds Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's NovaBridge Biosciences American Depositary Shares position peaked at $272K in Q1 2024.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.